Transaction · 0001817160-26-000019

Hansen Gwenn

Hansen Gwenn, CSO, reported a transaction classified as exercise at Nurix Therapeutics, Inc. involving 1452.000000 shares for an estimated $2700.72. Reported holdings after the transaction were 118679.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCSO
NRIXNurix Therapeutics, Inc.
Trade date
Sep 01, 2026
Filing date
Sep 01, 2026
View on SEC Insider profile
Estimated value$2.70kShares × reported price
Shares traded1.45k$1.86 per share
Holdings after118kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

NRIX price since this filing

Daily closing prices, with the filing date and available return windows
NRIX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -14.7%1w ago +0.0%1d ago +0.0%
Returns since7d -4.0%30d -14.3%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001817160-26-000019
Common Stock
Transaction date
Sep 01, 2026
Filed Sep 01, 2026, 09:19 PM · 0d delay
Shares
1,452 sh
$1.86 per share
Estimated value
$2.70k
Computed from shares × price
Holdings after
118,679 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Scientific Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

  2. F2

    The stock option vested as to 1/48 of the total shares monthly beginning June 10, 2019 until the option was fully vested on May 10, 2023.

Original filing · 0001817160-26-000019
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

NRIX